HPS Pharmacies wish to advise that Fresenius Kabi is experiencing a supply interruption for Fresofol® as follows:
This short-term supply interruption is expected to resolve by the end of this week or early next week. This supply interruption only relates to the 20mL presentation of Fresofol® 1% MCT/LCT. The 50mL and 100mL presentations are currently unaffected.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Fresenius Kabi on (02) 9391 5555 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates